GNA Biosolutions Closes $13.5M Series C Financing Round Backed by a US/EU consortium
Munich, Germany, August 5, 2019 – GNA Biosolutions GmbH, a molecular diagnostics company based in Germany, announced today that it has completed a $13.5M round of financing. The Series C financing round was joined by new investors including GreyBird Ventures, Occident, and Wachtumsfonds Bayern,... Read More →
Bigfoot Biomedical Announces Partnership with Allegheny Health Network to Advance Innovative Solution for People with Diabetes
Milpitas, CA, and Pittsburgh, PA, August 1, 2019 – Bigfoot Biomedical, Inc., and Allegheny Health Network (AHN) – a Highmark Health company – announced today a collaboration to further advance Bigfoot Biomedical’s first-in-kind data-driven solutions for optimizing the dosing and delivery... Read More →
Israeli companies chosen for MedTech Innovator Showcase
Medasense for pain management and Vectorious for heart-failure monitoring were among 50 companies selected from a field of 800 applicants. Israeli biomed companies Medasense and Vectorious were among 50 best-in-class device, diagnostics, and digital health technologies chosen forMedTech Innovator’s 2019... Read More →
Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study
NEW YORK, July 22, 2019 /PRNewswire/ — Nanowear, the leading nanotechnology-based connected-care and remote monitoring platform, today announced the clinical launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study. The study will initially be conducted at Penn State Milton... Read More →
Endotronix Enrolls First Patient in SIRONA II CE Mark Trial
LISLE, Ill., July 15, 2019 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced enrollment of the first patient in its prospective, multi-center, SIRONA II trial, in Europe. The 60-patient study will evaluate safety... Read More →
Centerline Biomedical Receives FDA 510(k) Clearance for Intra-Operative Positioning System
Centerline Biomedical, Inc. has announced that the company has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its flagship product, the Intra-Operative Positioning System, IOPS. A non-radiation-based surgical navigation system for minimally invasive surgery,... Read More →
Emovi Announces U.S. Commercial Launch of KneeKG In-Clinic Device
Emovi Inc. has announced the U.S. launch of KneeKG, the first in-clinic device that meets the global need for measuring knee function with objective and quantifiable data associated with mechanical knee markers and functional deficiencies. KneeKG is the first device to enable... Read More →
Day Zero Diagnostics Awarded Phase I SBIR Grant for Algorithm Development
Day Zero Diagnostics (DZD) said today it has received a Phase I Small Business Innovation Research (SBIR) award from the NIH’s National Institute of Allergies and Infectious Disease (NIAID) intended to fund the development of an algorithm to automate the... Read More →
AblaCare Announces Series A Financing of €10 Million by Sofinnova Partners for Innovative Infertility Treatment and Appoints Jodie Fam as CEO
PARIS–(BUSINESS WIRE)–AblaCare, a medical device company dedicated to transforming women’s health and fertility care, announced today that it has raised €10 million in Series A financing from Sofinnova Partners. The company also announced the appointment of seasoned medical device executive... Read More →
Dr. Amit Vohra Awarded the “Top 100 Leaders in Health Care” at IFAH, Vegas 2019
LAS VEGAS – July 9, 2019 – PRLog — Amit Vohra was conferred with the “Top 100 Leaders in Health Care” award for his significant contributions towards the health care sector at IFAH 2019, held at Caesars Palace, Vegas on June 18-20, 2019. Promaxo has... Read More →